Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Ampersand Biomedicines logo

Ampersand Biomedicines

Recent Finacing

Series B

Recent Raise

$65M

Ampersand Biomedicines' AND platform maps tissue-specific transcriptomic addresses and designs AND-Body therapeutics pairing localizers with small-molecule, protein, LNP, or nucleic-acid actuators for targeted conditional drug localization.

Founded 2020
Massachusetts, United States
11-50
Private
ampersand.bio
PitchBook

Highlights

Focus Areas

Biopharma
Biotechnology
Medical
Therapeutics

Recent Investors

Flagship Pioneering logo
Eli Lilly and Company logo

Financials

$115M

Total Raised

2

Funding rounds

2

Investors


Team

Upgrade to view the team

See the team members at Ampersand Biomedicines.